Karafotias, Ioasaf
Martini, Helene
Lee, Charlotte V.
Hunter, Terrence T. J.
Gurugama, Padmalal
Guckian, Mary
Steven, Rachael
Jolles, Stephen
Peakman, Mark
Fear, David
Ibrahim, Mohammad A. A. https://orcid.org/0000-0002-0116-597X
Article History
Received: 19 May 2023
Accepted: 28 October 2025
First Online: 25 November 2025
Declarations
:
: The study protocol was approved by the HRA and Health and Care Research Wales (HCRW) ethics committee (Approval REC reference: 20/YH/0015, IRAS 232824), complying with the Declaration of Helsinki.
: All participants signed and provided informed consent upon enrolment in the study.
: SJ has received support for conferences, speaker, advisory boards, trials, data and safety monitoring boards, and projects with CSL Behring, Takeda, Swedish Orphan Biovitrum, Biotest, Binding Site, Grifols, BPL, Octapharma, LFB, Pharming, GSK, Weatherden, Zarodex, Sanofi, and UCB Pharma. None of the other authors declares any conflict of interest.